Michael B Harris

California State University Long Beach - Long Beach / United States

Medical and Health Sciences / Physiology

AD Scientific Index ID: 848082

-

Registration, Add Profile,
Premium Membership

Print Your Certificate

Michael B Harris's MOST POPULAR ARTICLES

1-) Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival-a report from the Children\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s Oncology GroupPA Meyers, CL Schwartz, MD Krailo, JH Healey, ML Bernstein, D Betcher, ...Journal of clinical oncology 26 (4), 633-638, 20087772008

2-) Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexatePA Meyers, CL Schwartz, M Krailo, ES Kleinerman, D Betcher, ...Journal of clinical oncology 23 (9), 2004-2011, 20057462005

3-) Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651AM Goorin, DJ Schwartzentruber, M Devidas, MC Gebhardt, AG Ayala, ...Journal of clinical oncology 21 (8), 1574-1580, 20034352003

4-) Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children’s Oncology GroupSL Berg, SM Blaney, M Devidas, TA Lampkin, A Murgo, M Bernstein, ...Journal of Clinical Oncology 23 (15), 3376-3382, 20053872005

5-) Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II studyRL Saylors III, KC Stine, J Sullivan, JL Kepner, DA Wall, ML Bernstein, ...Journal of clinical oncology 19 (15), 3463-3469, 20013722001

ARTICLES

Add your articles